Answers are grounded in this paper and cite their sources.
Diabetic retinopathy (DR), a sight-threatening ocular complication of diabetes mellitus, is one of the main causes of blindness in the working-age population. Dyslipidemia is a potential risk factor for the development or worsening of DR, with conflicting evidence in epidemiological studies. Fenofibrate, an antihyperlipidemic agent, has lipid-modifying and pleiotropic (non-lipid) effects that may lessen the incidence of microvascular events.
No takes yet. Share an insight, caveat, or question.
Kartı et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: